Related Experiment Video
Updated: Jan 7, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Changes in Antimicrobial Resistance in Pediatric Urinary Pathogens Before, During, and After the COVID-19 Pandemic
Seon Hee Lim1, Kyo Jin Jo1, Shin Yun Byun1
1Department of Pediatrics, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea.
Insights
Pediatric urinary tract infections (UTIs) saw increased ciprofloxacin resistance during the COVID-19 pandemic, particularly in infants. This trend persisted post-pandemic, underscoring the need for better antibiotic stewardship.
Area of Science:
- Pediatric Infectious Diseases
- Antimicrobial Resistance (AMR)
- Epidemiology
Background:
- Pediatric urinary tract infections (UTIs) pose treatment challenges due to rising antimicrobial resistance (AMR).
- The COVID-19 pandemic influenced antibiotic prescribing patterns in children, but its effect on AMR trends was unclear.
- Investigating AMR trends in young children hospitalized with febrile UTI during different pandemic phases is crucial.
Purpose of the Study:
- To analyze antimicrobial resistance (AMR) trends in urinary pathogens from children under 24 months hospitalized with febrile UTI.
- To compare AMR patterns during the pre-, during-, and post-COVID-19 pandemic periods.
- To identify predictors of ciprofloxacin nonsusceptibility in pediatric febrile UTI.
Main Methods:
- Retrospective study of children aged <24 months hospitalized for first febrile UTI (2008-2023).
- Stratification by age (<100 days vs. 100 days-24 months) and pandemic period (pre-, during-, post-COVID-19).
- Interrupted time-series (ITS) analysis and logistic regression to assess trends and predictors of ciprofloxacin nonsusceptibility.
Main Results:
- Ciprofloxacin susceptibility significantly decreased during the COVID-19 pandemic, especially in infants <100 days.
- ITS analysis revealed an immediate 12.1% increase in ciprofloxacin nonsusceptibility at pandemic onset, which continued.
- Extended-spectrum β-lactamase (ESBL) production was the strongest predictor of ciprofloxacin resistance.
Conclusions:
- The study indicates a significant rise in ciprofloxacin nonsusceptibility in pediatric febrile UTI during the COVID-19 pandemic.
- Adult antibiotic use and clonal spread may drive AMR persistence and dissemination.
- Integrated antibiotic stewardship and genomic surveillance are essential for combating pediatric AMR.
Background:
Pediatric urinary tract infections (UTIs) are increasingly complicated to treat due to antimicrobial resistance (AMR). The coronavirus disease 2019 (COVID-19) pandemic has led to substantially reduced pediatric antibiotic prescribing, but its impact on resistance trends remains unclear. This study aimed to investigate the AMR trends in urinary pathogens from children under 24 months of age hospitalized with febrile UTI during the pre-, during-, and post-COVID-19 pandemic periods.
Methods:
We conducted a retrospective study of children aged <24 months who were hospitalized at a tertiary center in Korea between 2008 and 2023 for first febrile UTI. The patients were stratified by age (<100 days vs. 100 days to 24 months) and pandemic period (pre-, during-, and post-COVID-19). Interrupted time-series (ITS) analysis and multivariable logistic regression were used to assess the temporal trends and predictors of ciprofloxacin nonsusceptibility.
Results:
Ciprofloxacin susceptibility decreased significantly during the pandemic, especially among infants < 100 days. ITS analysis demonstrated an immediate 12.1% increase in ciprofloxacin nonsusceptibility at pandemic onset, which persisted thereafter. Extended-spectrum β-lactamase production was the strongest predictor of ciprofloxacin resistance.
Conclusions:
These findings suggest that adult antibiotic use and clonal dissemination may contribute to the persistence and spread of AMR, highlighting the need for integrated stewardship and genomic surveillance.
Related Concept Videos
Urine Studies II: Urine Culture and Sensitivity Test
Pharmacokinetics in Pediatric Patients: Drug Excretion
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection II: Pathophysiology
Development of Antibiotic Resistance
Antimicrobial Effectiveness

